Source link : https://www.newshealth.biz/health-news/early-data-for-glp-1-pill-faers-tirzepatide-reports-ai-diabetes-voice-screening/
Studies presented at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid included early data for oral amycretin, safety data for tirzepatide (Mounjaro, Zepbound), and voice screening for diabetes. Early Data for Oral Amycretin Twelve weeks of daily oral treatment with an investigational compound yielded significant weight loss in a phase […]
Author : News Health
Publish date : 2024-09-13 21:28:16
Copyright for syndicated content belongs to the linked Source.
Categories